Skip to main content
Livermore
Livermore
ZHEN

Ligand Pharmaceuticals Inc

LGND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000886163

In the last 90 days, Ligand Pharmaceuticals Inc insiders filed 0 open-market purchases and 6 sales; 416 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.

Other share classesLGNDZLGNXZLGNYZLGNZZ

Holders of 5% or more of LGND

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ligand Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of LGND
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A14.50%2.84M shares−1.10 ppfrom 15.60%Feb 5, 20252 filingsOct 17, 2025SEC
Invesco Ltd.13G6.10%1.22M sharesNewAug 13, 20261 filingAug 13, 2026SEC
Vanguard Portfolio Management LLC13G5.56%1.11M sharesNewMay 1, 20261 filingMay 1, 2026SEC
Janus Henderson Group PLC13G/A5.30%1.04M shares−0.20 ppfrom 5.50%Feb 11, 20216 filingsNov 14, 2025SEC
Vanguard Capital Management LLC13G5.00%997.6K sharesNewMay 1, 20261 filingMay 1, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

31 Schedule 13D and 13G filings on Ligand Pharmaceuticals Inc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on LGND
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 13, 20262:59 PM ETInvesco Ltd.13G6.10%1.22M sharesNewJun 30, 2026SEC
May 1, 20268:51 AM ETVanguard Portfolio Management LLC13G5.56%1.11M sharesNewMar 31, 2026SEC
May 1, 20268:39 AM ETVanguard Capital Management LLC13G5.00%997.6K sharesNewMar 31, 2026SEC
Mar 27, 202610:32 AM ETVanguard Group Inc13G/A0.00%0 shares–Below 5%Mar 13, 2026SEC
Nov 14, 202512:43 PM ETJanus Henderson Group PLC13G/A5.30%1.04M shares−0.20 ppfrom 5.50%Sep 30, 2025SEC
Oct 17, 20255:31 PM ETBlackRock, Inc.13G/A14.50%2.84M shares−1.10 ppfrom 15.60%Sep 30, 2025SEC
Aug 14, 202511:43 AM ETJanus Henderson Group PLC13G/A5.50%1.06M shares+0.20 ppfrom 5.30%Jun 30, 2025SEC
May 14, 202512:31 PM ETJanus Henderson Group PLC13G/A5.30%1.03M shares−0.10 ppfrom 5.40%Mar 31, 2025SEC
Feb 14, 202512:36 PM ETJanus Henderson Group PLC13G/A5.40%1.02M shares–Dec 31, 2024SEC
Feb 5, 20251:23 PM ETBlackRock, Inc.13G/A15.60%2.95M shares–Dec 31, 2024SEC
Feb 14, 2022Macquarie Group Ltd13G/AOld format–––SEC
Feb 14, 2022Cardinal Capital Management LLC13G/AOld format–––SEC
Feb 11, 2022Wasatch Advisors Inc13G/AOld format–––SEC
Feb 11, 2022State Street Corp13G/AOld format–––SEC
Feb 10, 2022Janus Henderson Group PLC13G/AOld format–––SEC
Feb 10, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 10, 2022William Blair Investment Management, LLC13G/AOld format–––SEC
Jan 27, 202211:00 AM ETBlackRock Inc.13G/AOld format–––SEC
Jan 25, 20223:03 PM ETBlackRock Inc.13G/AOld format–––SEC
Oct 12, 2021Vanguard Group Inc13G/AOld format–––SEC
May 7, 2021William Blair Investment Management, LLC13G/AOld format–––SEC
Feb 16, 2021Cardinal Capital Management LLC13G/AOld format–––SEC
Feb 16, 2021State Street Corp13GOld format–New–SEC
Feb 12, 2021Macquarie Group Ltd13GOld format–New–SEC
Feb 11, 2021Janus Henderson Group PLC13G/AOld format–––SEC
Feb 11, 2021William Blair Investment Management, LLC13G/AOld format–––SEC
Feb 11, 2021Renaissance Technologies LLC13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13G/AOld format–––SEC
Feb 9, 2021Wasatch Advisors Inc13GOld format–New–SEC
Feb 8, 20215:19 PM ETBank of America Corp13G/AOld format–––SEC
Jan 26, 20216:52 PM ETBlackRock Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Ligand Pharmaceuticals Inc shares.

No Form 144 notices for Ligand Pharmaceuticals Inc are on file.